Showing results (1701-1710 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|September 11, 2007
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association studyMichael A van Es, Paul W Van Vught, Hylke M Blauw, et al.
The Lancet. Neurology|July 20, 2007
Metabolic and molecular imaging in neuro-oncologyKarl Herholz, David Coope, Alan Jackson
The Lancet. Neurology|September 22, 2006
Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre studyJens Allendoerfer, Michael Goertler, Gerhard-Michael von Reutern, et al.
The Lancet. Neurology|September 22, 2006
Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndromeWalter Paulus, Claudia Trenkwalder
The Lancet. Neurology|October 21, 2006
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyAlexis Elbaz, Lorene M Nelson, Haydeh Payami, et al.
The Lancet. Neurology|October 21, 2006
Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive studyLisa F Barcellos, Brinda B Kamdar, Patricia P Ramsay, et al.
The Lancet. Neurology|July 8, 2008
Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based studyRichard F M Chin, Brian G R Neville, Catherine Peckham, et al.
The Lancet. Neurology|July 19, 2008
Biomarkers for cognitive impairment and dementia in elderly peopleJoshua A Sonnen, Kathleen S Montine, Joseph F Quinn, et al.
The Lancet. Neurology|July 19, 2008
NMDA receptors in clinical neurology: excitatory times aheadLorraine V Kalia, Suneil K Kalia, Michael W Salter
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Pageof 200